Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

1 to 25 of 896 results

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

29-07-2014

Privately-held California, USA-based specialty vaccine firm PaxVax says it has acquired the oral typhoid…

LicensingMergers & AcquisitionsPaxVaxPharmaceuticalProductionSwitzerlandVaccinesVivotif

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Pfizer to acquire generics firm InnoPharma for up to $360 million

Pfizer to acquire generics firm InnoPharma for up to $360 million

17-07-2014

Having failed (so far) in its mega billion dollar ($116 billion) attempt to buy Anglo-Swedish drug major…

GenericsInnoPharmaMergers & AcquisitionsOncologyOphthalmicsPfizer

Strides Arcolab makes strategic investment in Oncobiologics

Strides Arcolab makes strategic investment in Oncobiologics

16-07-2014

India’s Strides Arcolab has made a series of strategic investments in Oncobiologics, a privately held…

BiosimilarsBiotechnologyFinancialIndiaMergers & AcquisitionsOncobiologicsStrides Arcolab

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

UK Business Secretary to set out new takeover rules

UK Business Secretary to set out new takeover rules

13-07-2014

UK Business Secretary Vince Cable is shortly to announce new regulations to deal with foreign takeover…

LegalMergers & AcquisitionsPfizerPharmaceuticalUKVince Cable

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Stada Arz acquires Flexitol rights for UK and Ireland

Stada Arz acquires Flexitol rights for UK and Ireland

10-07-2014

Thornton & Ross, the UK subsidiary of German generic and branded drugmaker Stada Arzneimittel, has purchased…

DermatologicalsFlexitolIrelandMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & RossUK

Baxter buys AesRx, gaining rights to investigational SCD drug

Baxter buys AesRx, gaining rights to investigational SCD drug

10-07-2014

US drugmaker Baxter International said yesterday that it has acquired AesRx, a private US biopharmaceutical…

Aes-103AesRxBaxter InternationalBiotechnologyHematologyMergers & AcquisitionsRare diseasesUSA

MabVax Therapeutics and Telik close merger

MabVax Therapeutics and Telik close merger

09-07-2014

USA-based MabVax Therapeutics, a privately held cancer immunotherapy company, and Telik, a publicly-traded…

MabVax TherapeuticsMergers & AcquisitionsOncologyPharmaceuticalTelikUSA

Salix Pharma to combine with unit of Italy’s Cosmo

Salix Pharma to combine with unit of Italy’s Cosmo

09-07-2014

US drugmaker Salix Pharmaceuticals has agreed to combine with an Ireland-based unit of Italy’s Cosmo…

Cosmo PharmaceuticalsCosmo TechnologiesGastro-intestinalsMergers & AcquisitionsPharmaceuticalSalix Pharmaceuticals

AbbVie comes up with higher offer for Shire of $51.5 billion

AbbVie comes up with higher offer for Shire of $51.5 billion

08-07-2014

As has been widely expected following the meetings last week with major shareholders of Ireland headquartered…

AbbVieMergers & AcquisitionsPharmaceuticalShire

Mariel Therapeutics to acquire Stryker's BMP-7 assets

Mariel Therapeutics to acquire Stryker's BMP-7 assets

08-07-2014

US clinical-stage drug developer Mariel Therapeutics has entered into a definitive agreement to acquire…

Anti-Arthritics/RheumaticsMariel TherapeuticsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalStryker Corp

Hospira completes buy of Orchid's API production and R&D facility

Hospira completes buy of Orchid's API production and R&D facility

06-07-2014

US provider of injectable drugs and infusion technologies Hospira says it has completed the acquisition…

GenericsHospiraIndiaMergers & AcquisitionsOrchid Chemicals & PharmaceuticalsProduction

1 to 25 of 896 results

Back to top